immunochemotherapyRituximabPrednisoneCyclophosphamideHydroxydaunorubicinOncovinfollicular lymphomahistiocytic/dendritic cell sarcoma
…owed by evolution into HGBCL-MYC/BCL2 responding transiently to immunochemotherapy, emphasising the value of repeated histological and molecular r…